SC
Scancell Holdings plc
SCNLF · OTC
$0.14 +0.00% (+$0.00)
1M +4.29%
Market Cap £108.2M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 22.96x
EV/EBITDA N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 260.50%
Op. margin 318.43%
FCF margin 136.13%
Quality
4 /100
Poor ROA 53.15%
Asset turnover 0.20x
ROIC 144.56%
Debt
10 /100
High Int. coverage -10.86x
Current ratio 0.77x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 108.62%
Profitable years 0
Beta 0.74x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SCNLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Phillip John L'Huillier
Employees
61
Headquarters
Oxford
Prihajajoči dogodki
23 OKT.
Earnings
Upcoming earnings report
04 FEB.
Earnings
Upcoming earnings report